A live, clinician-only case discussion held monthly through OncoMenopause and the OncoMenopause Consortium®. Each session works through real, de-identified cases at the intersection of oncology and menopause care — the diagnostic questions and treatment decisions that don't have a clean answer in the guidelines. Dr. Milana V. Dolezal kicks off the series.

Milana V. Dolezal, MD, MSci, is a board-certified hematologist-oncologist and Clinical Associate Professor in the Division of Oncology at Stanford School of Medicine, where she practices at Stanford Medicine Cancer Center in Emeryville. Her clinical and research work centers on breast cancer, with particular expertise in triple-negative breast cancer, fertility preservation in breast cancer patients, and treatment adherence. She previously served as Clinical Scientist and Associate Medical Director in the BioOncology Therapeutics unit at Genentech, bringing rare depth in both translational science and drug development to her academic oncology practice. Dr. Dolezal has co-authored peer-reviewed research published in the Journal of Clinical Oncology, Cancer, and other leading journals, and contributed the chapter "Progression from Hormone-Dependent to Hormone-Independent Breast Cancer" to the Oxford University Press textbook Hormones, Genes and Cancer. She has presented her research at the American Association for Cancer Research, the American Society of Clinical Oncology, and the European Cancer Organisation.